| Dr Glynne Edwards, MD | |
|
2540 N Healthy Way, Fremont, NE 68025-2315 | |
| (402) 727-7796 | |
| Not Available |
| Full Name | Dr Glynne Edwards |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 21 Years |
| Location | 2540 N Healthy Way, Fremont, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114234895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD-45116 (Iowa) | Secondary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 34681 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Fremont Health | Fremont, NE | Hospital |
| The Nebraska Methodist Hospital | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nebraska Methodist Hospital | 6901707447 | 118 |
| Physicians Clinic Inc | 4880506062 | 497 |
News Archive
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
Researchers from North Carolina State University have found that dogs can suffer from the same type of autoimmune encephalitis that people do. The finding could lead to better screening methods for diagnosis and possibly more effective treatments for canine encephalitis.
When a pregnant woman is diagnosed with cancer, she and her family and doctors are faced with difficult decisions about her health and that of her unborn child. It is known that giving chemotherapy in the first 12 weeks, when the baby's organs are still forming, raises the chances of birth defects. Postponing the treatment, however, could allow the cancer to spread. Over the last decade, doctors have been more willing to use chemotherapy after the first trimester, but there have been worries that the child's brain and heart could suffer damage.
A new long-term study finds over 20 years, only one in five women who have mammograms every two years will have to undergo follow up evaluation for a false positive finding. Only one in 16 will have an unnecessary invasive procedure over two decades.
› Verified 2 days ago
| Entity Name | Physicians Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821049156 PECOS PAC ID: 4880506062 Enrollment ID: O20031105000345 |
News Archive
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
Researchers from North Carolina State University have found that dogs can suffer from the same type of autoimmune encephalitis that people do. The finding could lead to better screening methods for diagnosis and possibly more effective treatments for canine encephalitis.
When a pregnant woman is diagnosed with cancer, she and her family and doctors are faced with difficult decisions about her health and that of her unborn child. It is known that giving chemotherapy in the first 12 weeks, when the baby's organs are still forming, raises the chances of birth defects. Postponing the treatment, however, could allow the cancer to spread. Over the last decade, doctors have been more willing to use chemotherapy after the first trimester, but there have been worries that the child's brain and heart could suffer damage.
A new long-term study finds over 20 years, only one in five women who have mammograms every two years will have to undergo follow up evaluation for a false positive finding. Only one in 16 will have an unnecessary invasive procedure over two decades.
› Verified 2 days ago
| Entity Name | Nebraska Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689628372 PECOS PAC ID: 6901707447 Enrollment ID: O20040116000781 |
News Archive
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
Researchers from North Carolina State University have found that dogs can suffer from the same type of autoimmune encephalitis that people do. The finding could lead to better screening methods for diagnosis and possibly more effective treatments for canine encephalitis.
When a pregnant woman is diagnosed with cancer, she and her family and doctors are faced with difficult decisions about her health and that of her unborn child. It is known that giving chemotherapy in the first 12 weeks, when the baby's organs are still forming, raises the chances of birth defects. Postponing the treatment, however, could allow the cancer to spread. Over the last decade, doctors have been more willing to use chemotherapy after the first trimester, but there have been worries that the child's brain and heart could suffer damage.
A new long-term study finds over 20 years, only one in five women who have mammograms every two years will have to undergo follow up evaluation for a false positive finding. Only one in 16 will have an unnecessary invasive procedure over two decades.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Glynne Edwards, MD Po Box 3755, Omaha, NE 68103-0755 Ph: (402) 354-2100 | Dr Glynne Edwards, MD 2540 N Healthy Way, Fremont, NE 68025-2315 Ph: (402) 727-7796 |
News Archive
MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody (MAB) developed to neutralize the rabies virus.
Researchers from North Carolina State University have found that dogs can suffer from the same type of autoimmune encephalitis that people do. The finding could lead to better screening methods for diagnosis and possibly more effective treatments for canine encephalitis.
When a pregnant woman is diagnosed with cancer, she and her family and doctors are faced with difficult decisions about her health and that of her unborn child. It is known that giving chemotherapy in the first 12 weeks, when the baby's organs are still forming, raises the chances of birth defects. Postponing the treatment, however, could allow the cancer to spread. Over the last decade, doctors have been more willing to use chemotherapy after the first trimester, but there have been worries that the child's brain and heart could suffer damage.
A new long-term study finds over 20 years, only one in five women who have mammograms every two years will have to undergo follow up evaluation for a false positive finding. Only one in 16 will have an unnecessary invasive procedure over two decades.
› Verified 2 days ago
Dr. Martin F Sears, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1935 East Military Avenue, Suite 2, Fremont, NE 68025 Phone: 402-721-5657 Fax: 402-753-9179 | |
Thomas S Robertson, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 680 E Fremont Medical Park Dr, Suite 100, Fremont, NE 68025 Phone: 402-727-5200 Fax: 402-721-5230 | |
Dr. Muhammad S Haroon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 E 23rd St, Fremont, NE 68025 Phone: 402-941-7030 Fax: 402-941-7032 | |
Angela C Sukstorf, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 450 E 23rd St, Fremont, NE 68025 Phone: 402-941-1359 | |
Richard J Seitz, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 680 E. Fremont Medical Park Dr., Suite 100, Fremont, NE 68025 Phone: 402-727-5200 | |
J Michael Adams, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 680 E Fremont Medical Park Dr, Suite 100, Fremont, NE 68025 Phone: 402-727-5200 Fax: 402-721-5230 |